garu – PreTect HPV E6/E7 mRNA

We are pleased to share this article by rad et al., reporting the long-term performance of a five-type HPV mRNA test to predict cervical intraepithelial neoplasia grade 3 or worse (CIN3+) during up to 12 years of follow-up of 9582 cytology negative women at baseline.

20 de September de 2023

The 10-year cumulative incidence of CIN3+ among the HPV mRNA-positive women was 20.8% (CI: 16.2–25.4), whilst 1.1% in HPV mRNA negative women at baseline. The

We are happy to share this work by sørbye et al., reporting the prevalence and distribution of HPV types in 179 cervical cancer cases during a 20-year period preceding systematic hpv vaccination in norway.

20 de September de 2023

Understanding the distribution of HPV types in cervical cancer cases is crucial for evaluating the effectiveness of HPV screening and vaccination in reducing the burden

Ipvc 2023 – 35 th International Papillomavirus conference, coming togetherfor HPV eliminination

21 de April de 2023

Performance of a 7-type HPV mRNA test compared to Liquid-Based Cytology in triage of HPV-DNA primary screen positive women.

News PreTect

We are pleased to share this article by rad et al., reporting the long-term performance of a five-type HPV mRNA test to predict cervical intraepithelial neoplasia grade 3 or worse (CIN3+) during up to 12 years of follow-up of 9582 cytology negative women at baseline.

We are happy to share this work by sørbye et al., reporting the prevalence and distribution of HPV types in 179 cervical cancer cases during a 20-year period preceding systematic hpv vaccination in norway.

Ipvc 2023 – 35 th International Papillomavirus conference, coming togetherfor HPV eliminination

We are pleased to share this article by rad et al., reporting the long-term performance of a five-type HPV mRNA test to predict cervical intraepithelial neoplasia grade 3 or worse (CIN3+) during up to 12 years of follow-up of 9582 cytology negative women at baseline.

We are happy to share this work by sørbye et al., reporting the prevalence and distribution of HPV types in 179 cervical cancer cases during a 20-year period preceding systematic hpv vaccination in norway.

Ipvc 2023 – 35 th International Papillomavirus conference, coming togetherfor HPV eliminination